Document Detail


Long-term suppressive therapy for pulmonary aspergilloma in an immunocompromised man with AIDS. Is it always necessary?
MedLine Citation:
PMID:  19451335     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Aspergillus infections are rare opportunistic infections in the course of AIDS and they mostly present as invasive pulmonary disease. Owing to the prolonged survival of profoundly immunocompromised patients with AIDS, invasive pulmonary aspergillosis is being reported with increased frequency. However, although pulmonary aspergilloma has been well described in immunocompetent patients, it has been rarely reported in AIDS patients. The treatment for pulmonary aspergilloma remains challenging and often needs lifelong treatment to minimize fatal haemoptysis, which can occur in up to 25%, and progression to secondary invasive aspergillosis. We report a case of pulmonary aspergilloma in a severely immunocompromised patient with AIDS who stopped taking systemic antifungal treatment in April 1998 and remained well with little progression of invasive aspergillosis up until March 2002 when he died of acute pancreatitis related to a drug interaction of didanosine and tenofovir.
Authors:
K Yoganathan
Related Documents :
10960995 - Aids-dedicated nurses: what can be learned from their perceptions and experiences.
7706825 - Coccidioidomycosis among persons with aids in the united states.
15331115 - Voice problems as side effects of inhaled corticosteroids in asthma patients--a prevale...
9275325 - Relationship between high incidence of adverse dapsone reactions and slow acetylate phe...
1417635 - Serious suicide attempts among adolescents in custody.
18635685 - Exact subgrid interface correction schemes for elliptic interface problems.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  International journal of STD & AIDS     Volume:  20     ISSN:  0956-4624     ISO Abbreviation:  Int J STD AIDS     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-05-19     Completed Date:  2009-08-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9007917     Medline TA:  Int J STD AIDS     Country:  England    
Other Details:
Languages:  eng     Pagination:  434-6     Citation Subset:  IM; X    
Affiliation:
Singleton Hospital, Sketty, Swansea SA2 8QA, Wales, UK. kathir.yoganathan@swansea-tr.wales.nhs.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
AIDS-Related Opportunistic Infections / drug therapy*,  microbiology
Adenine / adverse effects,  analogs & derivatives
Anti-HIV Agents / adverse effects
Antifungal Agents* / administration & dosage,  therapeutic use
Aspergillosis / drug therapy*,  microbiology,  radiography
Didanosine / adverse effects
Drug Administration Schedule
Drug Interactions
Fatal Outcome
HIV Infections / complications*
Humans
Immunocompromised Host*
Lung Diseases, Fungal / drug therapy*,  radiography
Male
Middle Aged
Pancreatitis / etiology
Phosphonic Acids / adverse effects
Reverse Transcriptase Inhibitors / adverse effects
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anti-HIV Agents; 0/Antifungal Agents; 0/Phosphonic Acids; 0/Reverse Transcriptase Inhibitors; 107021-12-5/tenofovir; 69655-05-6/Didanosine; 73-24-5/Adenine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Suppurative iliac lymphadenitis masquerading as appendicitis in an HIV-infected patient.
Next Document:  Vulval lymphoedema following pulmonary tuberculosis.